Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
154.2 EUR | -1.46% |
|
+0.44% | +10.08% |
07-12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
07-12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
Official Publications
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
Annual ESG Report | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
Dividends | CO |
- Stock Market
- Equities
- ABBV Stock
- 4AB Stock
- News AbbVie Inc.
- Official Publications